Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19

Showing 19 citing articles:

Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 89
Can Compounds of Natural Origin Be Important in Chemoprevention? Anticancer Properties of Quercetin, Resveratrol, and Curcumin—A Comprehensive Review
Elżbieta Cecerska‐Heryć, Z Wiśniewska, Natalia Serwin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4505-4505
Open Access | Times Cited: 11
Molecular Docking Study and 3D-QSAR Model for Trans-Stilbene Derivatives as Ligands of CYP1B1
Zbigniew Dutkiewicz, Renata Mikstacka
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1002-1002
Open Access
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks
Jong-Won Kim, Hung‐Chun Tung, Bin Yang, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100045-100045
Closed Access
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2898-2898
Open Access | Times Cited: 6
Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer
Erica Yada, Rika Kasajima, Atsushi Niida, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1396-1396
Open Access | Times Cited: 14
Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells
Jianping Mao, Dong Wang, Ping Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16451-16480
Closed Access | Times Cited: 10
CYP1B1: A Promising Target in Cancer Drug Discovery
Marciéli Fábris, Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 9, pp. 981-988
Closed Access | Times Cited: 5
Methoxy and methylthio-substituted trans-stilbene derivatives as CYP1B1 inhibitors – QSAR study with detailed interpretation of molecular descriptors
Natalia Piekuś-Słomka, Mariusz Zapadka, Bogumiła Kupcewicz
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 11, pp. 104204-104204
Open Access | Times Cited: 8
Design and Synthesis of Novel Near-Infrared Fluorescence Probes Based on an Open Conformation of a Cytochrome P450 1B1 Complex for Molecular Imaging of Colorectal Tumors
Dongmei Chen, Ruining Li, Qi Shao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16032-16050
Closed Access | Times Cited: 4
Targeting Cytochrome P450 Enzymes in Ovarian Cancers: new approaches for Tumour-Selective Interventions
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Omar H. Abu-azzam, et al.
(2023)
Open Access | Times Cited: 3
Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations
Zbigniew Dutkiewicz, Renata Mikstacka
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11481-11481
Open Access | Times Cited: 2
Impact of residence on the association between benzo[a]pyrene-DNA adduct levels and CYP1B1 gene polymorphisms in breast cancer patients
Ali Hussein Shakir Al-Jailawi, Hayder Abdul-Amir Makki Al-Hindy, Hayder O. Hashim
Review of Clinical Pharmacology and Pharmacokinetics - International Edition (2024) Vol. 38, Iss. Sup2, pp. 173-176
Open Access
Insights into the structural and interactional aspects of 1-phenyl-5-(thiophen-2-yl)-1H-tetrazole: crystallographic, Hirshfeld surface, computational, and docking analyses
P. Akhileshwari, Ramesh Preetham, M. A. Sridhar, et al.
Structural Chemistry (2024)
Closed Access
CYP1B1 and MYOC Gene Analysis of Patients with Primary Congenital Glaucoma in the Cukurova Region of Turkey
Ahsen Cavusoglu Akbas, Elif Erdem, Sevcan Tuğ Bozdoğan, et al.
Journal of Pediatric Genetics (2023) Vol. 13, Iss. 04, pp. 277-282
Closed Access | Times Cited: 1
Computational Investigation of Ligand Binding of Flavonoids in Cytochrome P450 Receptors
Philippe B. Wilson, Chiemela S. Odoemelam, Elena Hunter, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 45, pp. 3637-3648
Closed Access | Times Cited: 2
Association of Leu432Val (rs1056836) polymorphism of the CYP1B1 gene with lipid profile in hypertensive Slovak women
Darina Falbová, Lenka Vorobeľová, Veronika Candráková Čerňanová, et al.
Anthropological Review (2022) Vol. 85, Iss. 2, pp. 1-12
Open Access | Times Cited: 1
Novel targets in drug discovery
Satish Jankie, Sunil Singh, Nicola Laurieri, et al.
Elsevier eBooks (2023), pp. 709-726
Closed Access
Special Issue of “Synthesis, Biological Evaluation and Molecular Modeling of Enzyme Inhibitors”
Renata Mikstacka, Zbigniew Dutkiewicz, Marcin Wierzchowski
Processes (2023) Vol. 11, Iss. 11, pp. 3128-3128
Open Access
Page 1

Scroll to top